Last reviewed · How we verify

NCT05879237

Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children

Status unknown NA Last updated 30 May 2023
What this trial tests

NA trial testing Vitamin D3 in Helicobacter Pylori Infection in 200 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
1 December 2023
10 December 2023

Quick facts

Lead sponsorMinia University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment200
Start date1 June 2023
Primary completion1 December 2023
Estimated completion10 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 4 to 18, any sex, with Helicobacter Pylori Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the efficacy of vitamin D in conjunction with Helicobacter pylori treatment in children in eradication of helicobacter pylori.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin D3

Trials testing the same drug.

Other recruiting trials for Helicobacter Pylori Infection

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05879237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing